Internal Medicine, Nephrology · Chalmette, LA
NPI
1396748828
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4020 Paris Rd
Chalmette, LA, 70043
Phone (504) 277-8423
Groups this clinician bills Medicare through
Medicare paid, 2024
$87K
950 services
Medicare patients, 2024
216
Average age 73
Drug cost, 2024
$1.1M
2,366 prescriptions
Company payments, 2025
$723
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arzu N Hatipoglu was code 90962 (esrd related services (not dialysis)), 266 times for 43 patients. In total Arzu N Hatipoglu billed 950 services in 14 codes, and Medicare paid $87K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-10-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90962 ESRD Related Services (not dialysis) | Office | 266 | 43 | $149.17 | $40K |
| 99214 Office E&M - Established | Office | 202 | 117 | $79.88 | $16K |
| 90961 ESRD Related Services (not dialysis) | Office | 79 | 27 | $218.92 | $17K |
| 99233 Hospital E&M - Subsequent | Facility | 54 | 15 | $86.08 | $4,648 |
| 90935 Hemodialysis | Facility | 37 | 28 | $50.77 | $1,879 |
| 99204 Office E&M - New | Office | 25 | 25 | $107.13 | $2,678 |
| 99223 Hospital E&M - Initial | Facility | 13 | 12 | $123.93 | $1,611 |
By year: 2022 $130K for 802 services; 2023 $92K for 678 services; 2024 $87K for 950 services.
Medicare prescription drug claims, 2024
In 2024, the drug Arzu N Hatipoglu prescribed most often to Medicare patients was Furosemide, with 272 prescriptions and refills. In total Arzu N Hatipoglu wrote 2,366 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Furosemide Generic | 272 | 514 | 82 | $1,437 |
| Farxiga Dapagliflozin Propanediol | 190 | 262 | 35 | $149K |
| Amlodipine Besylate Generic | 176 | 374 | 49 | $693 |
| Sevelamer Carbonate Generic | 150 | 193 | 41 | $18K |
| Losartan Potassium Generic | 120 | 291 | 46 | $928 |
| Allopurinol Generic | 102 | 253 | 40 | $745 |
| Hydralazine Hcl Generic | 90 | 132 | 21 | $713 |
| Carvedilol Generic | 57 | 89 | 16 | $437 |
| Lisinopril Generic | 46 | 130 | 15 | $268 |
| Lokelma Sodium Zirconium Cyclosilicate | 42 | 51 | Under 11 | $20K |
| Tamsulosin Hcl Generic | 39 | 86 | 12 | $324 |
| Calcium Acetate Generic | 38 | 47 | 14 | $2,879 |
| Jynarque Tolvaptan | 37 | 37 | Under 11 | $734K |
| Nifedipine Er Nifedipine | 34 | 66 | 12 | $277 |
| Clonidine Generic | 34 | 43 | Under 11 | $3,812 |
Brand drugs: 466 claims; generic drugs: 1,900 claims; opioid claims: 40.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Arzu N Hatipoglu $723 ($723 in general payments such as food, travel and fees) from 9 companies. The largest payer was Amgen Inc. with $233.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 19 | $233 |
| Calliditas Therapeutics US Inc. | 9 | $218 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $80.75 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 1 | $58.17 |
| Aurinia Pharma U.S., Inc. AUPH | 2 | $39.42 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $25.91 |
| Vifor Pharma, Inc. | 1 | $24.25 |
| Akebia Therapeutics Inc AKBA | 1 | $23.72 |
| Mallinckrodt Hospital Products Inc. | 1 | $19.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.